First Tracks Biotherapeutics Inc
TRAX | NASDAQ
$45.08
-$0.15 (-0.32%)
At close: Oct 30, 2026, 4:00 PM ET
$45.56
+$0.48 (+1.06%)
Pre-market:
Nov 2, 2026, 3:40 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 |
|---|---|---|---|
Net Income | -166.09M | -163.71M | -106.15M |
Depreciation & Amortization | 2.42M | 2.4M | 2.38M |
Stock-Based Compensation | 32.3M | 26.83M | 18.39M |
Other Working Capital | -1.52M | 1.18M | -5.49M |
Other Non-Cash Items | -10.04M | -10.31M | -10.52M |
Deferred Income Tax | n/a | n/a | n/a |
Change in Working Capital | -1.52M | 18.99M | 2.9M |
Operating Cash Flow | -142.93M | -125.81M | -93M |
Capital Expenditures | -87K | -358K | -807K |
Cash Acquisitions | n/a | n/a | n/a |
Purchase of Investments | n/a | -380.38M | -303.92M |
Sales Maturities Of Investments | n/a | 476.13M | 449.48M |
Other Investing Acitivies | 228.12M | n/a | n/a |
Investing Cash Flow | 228.03M | 95.4M | 144.75M |
Debt Repayment | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a |
Other Financial Acitivies | 30.01M | n/a | n/a |
Financial Cash Flow | 30.01M | 117.52M | -87.09M |
Net Cash Flow | 115.12M | 87.12M | -35.34M |
Free Cash Flow | -143.01M | -126.16M | -93.81M |
Adj. Free Cash Flow | -175.31M | -152.99M | -112.2M |
Maintenance CapEx | -87K | -358K | -807K |
Growth CapEx | n/a | n/a | n/a |
Owner Earnings | -143.01M | -126.16M | -93.81M |
Add to Watchlist
Select watchlists to add or remove TRAX